Canomiks Wins 2025 NutraIngredients-USA Award for
Groundbreaking Botanical Testing Solution

Rochester, MN – June 24, 2025 – Canomiks, a Minnesota-based life sciences startup, has won a 2025 NutraIngredients-USA Award for its groundbreaking Bio-B2B™ technology. This platform is the first end-to-end solution designed to evaluate the efficacy, safety, and batch-to-batch consistency of botanical ingredients—an urgent need in today’s supplement and natural products industry.

The NutraIngredients-USA Awards celebrate excellence across the nutrition and dietary supplements sector, recognizing outstanding achievements, scientific innovation, and leadership. Canomiks received the "Nutrition Research Project" award at the July 14 ceremony in Chicago for its transformative work in botanical science.

“Although not required by the FDA, biological efficacy testing for botanicals helps confirm product quality and supports safety,” said Dr. Leena Pradhan-Nabzdyk, CEO and Co-Founder of Canomiks. “Bio-B2B™ offers an efficient, cost-effective, and science-driven approach to validating botanical efficacy—addressing critical challenges like ingredient variability and adulteration. It raises industry standards, helps companies stand out in a crowded market, and empowers consumers to make more informed choices.”

Leveraging AI, genomics, and high-throughput biological testing, the Bio-B2B™ platform enables rapid validation of biological efficacy, detects contaminants and adulterants through functional genomics, and ensures traceability and transparency across ingredient batches and sources. These capabilities support science-backed claims and regulatory readiness.

With its unique blend of multi-omics science, AI, and customizable bioassays, Bio-B2B™ is the only platform capable of delivering functional and safety insights at scale. Backed by a National Science Foundation grant, the platform enables leading brands and suppliers to confidently validate ingredients—such as turmeric and elderberry—before production, supporting differentiation in a competitive, quality-focused market.

About Canomiks
Canomiks is a life sciences company advancing the future of functional foods, beverages, and dietary supplements through innovative genomics, bioinformatics, and AI-based solutions. Offering R&D and preclinical services, Canomiks supports CPG companies, ingredient suppliers, and manufacturers in developing and validating scientifically backed ingredients and products.

Founded by three Harvard scientists, Canomiks leverages proprietary intellectual property to bring truth, transparency, and trust to the natural products market. The company’s vision—“Make Food as Medicine a Reality®”—drives its mission to improve community health and sustainability. For more information, visit www.canomiks.com.